Thursday
10:30-11:00
Networking Hub

Exploring the early complications of T2D: What have the SGLT2 inhibitors taught us?

Kåre Birkeland (Norway)
Cardio-renal complications of T2D
Mikhail Kosiborod (USA)
The case for early intervention with SGLT2 inhibitors
All faculty
Q&A session
Hosted by: